View larger version (14K): [in this window] [in a new window] [Download PPT slide]   Figure 2. Reduced IgE switching in IkL/L B cells despite normal GLT expression. (A) Iµ-C transcript expression in B220+ WT and IkL/L B cells after 72 h of stimulation with LPS + IL-4 was analyzed by RT-qPCR. The Iµ promoter is equally active in WT and IkL/L cells (Fig. 4, A–D), indicating that Iµ-C transcripts can be faithfully compared between genotypes to quantify IgE-switched cells. (B) RT-qPCR for GLT expression after 48 h of LPS + IL-4 stimulation. Igβ was used as a loading control and all values were normalized to WT. Significance was determined by a two-tailed t test assuming unequal variance (**, P < 0.02). Graphs represent means plus SD of two (A) or three (B) independent experiments. Neither Iµ-C transcripts nor GLTs were detected in other conditions (not depicted).

It was also possible that the increased IgG_2b⁺ and IgG_2a⁺ populations in Ik^L/L cultures could be caused by the expansion of autoreactive cells that had previously switched in vivo, rather than specific CSR defects, considering the lower activation thresholds of Ik^L/L B cells (21) and the production of autoantibodies in transgenic mice expressing a B cell–restricted dominant-negative Ikaros isoform (27). Thus, isotype expression was analyzed using whole and bona fide unswitched B cells (B220⁺, and CD43^–IgG/A^– and CD43^–IgM⁺, respectively) that were stimulated with LPS, LPS + IFN-, and LPS + IL-4. Regardless of purification strategy, Ik^L/L cultures exhibited consistent and significant increases in IgG_2b⁺ and IgG_2a⁺ (and IgG₃⁺ with LPS + IL-4) cells compared with WT cultures (Fig. S4). Further, there were no significant differences in IgG_2b or IgG_2a expression between B220⁺, CD43^–IgG/A^–, and CD43^–IgM⁺ Ik^L/L cultures (Fig. S4). Thus, the aberrant isotype expression by Ikaros-deficient B cells results from defects in CSR and not from the expansion of in vivo–switched cells.

In summary, Ik^L/L cells (a) are more likely to undergo CSR, (b) display enhanced and ectopic CSR to IgG_2b and IgG_2a regardless of stimulation, and (c) show reduced CSR to all other isotypes (except for ectopic CSR to IgG₃ after LPS + IL-4). Therefore, Ikaros deficiency results in a B cell–intrinsic defect in isotype specification during CSR.

Ikaros function is required during CSR
Because Ikaros is expressed throughout B cell development and controls processes such as V(D)J recombination, which may affect the B cell repertoire (19, 20), we asked if Ikaros is required in mature B cells during CSR. WT B cells were stimulated for 24 h with LPS to induce CSR, and were then transduced with retroviruses encoding the dominant-negative Ikaros 6 (Ik6) isoform and a truncated human nerve growth factor receptor (NGFR) reporter. The Ik6 isoform lacks DNA binding domain zinc fingers and, upon dimerization, inhibits DNA binding by functional Ikaros isoforms (28). 72 h after infection, switching and NGFR expression were analyzed by FACS. WT cells transduced with control virus (NGFR^hi) switched exclusively to IgG₃ and IgG_2b, as did uninfected cells (NGFR^–) from WT cultures transduced with Ik6-NGFR (Fig. 3). Ik6-NGFR^hi cells, however, exhibited a threefold increase in IgG_2b⁺ cells, ectopic CSR to IgG_2a, 30–50% fewer IgG₃⁺ cells, and more switched cells (Fig. 3 and Fig. S5 A). Thus, inhibiting Ikaros function in mature WT B cells during CSR recapitulated the Ik^L/L switching phenotype. Similarly, transduction of Ik^L/L cells with the full-length Ik1 isoform rescued Ik^L/L switching defects (Fig. S5, B and C). Importantly, equally effective rescue was achieved with the truncated Ik1 isoform that lacks exon 2–derived protein sequences and is expressed at low levels in Ik^L/L cells, indicating that these truncated Ikaros proteins function like full-length Ikaros during CSR (Fig. S5, B and C) (21). Collectively these results show that Ikaros regulates CSR specificity and efficiency in mature B cells.

View larger version (17K): [in this window] [in a new window] [Download PPT slide]   Figure 3. Ikaros regulates CSR in mature B cells. CFSE-stained B220+ WT B cells were activated for 24 h with LPS to induce CSR, infected with retroviruses encoding the NGFR reporter alone or with the dominant-negative Ik6 isoform (Ik6-NGFR), and stimulated for another 72 h with LPS. Ig and NGFR expression were analyzed by FACS. Numbers represent percentages of NGFR–, NGFR+, or IgG+ cells. The data are representative of four independent experiments (Fig. S5 A provides a statistical analysis).

Ikaros deficiency results in deregulated S region transcription
To determine if Ikaros controls CSR specificity by regulating S region transcription, we measured GLT levels for µ, 3, 1, 2b, 2a, and in WT and Ik^L/L B cells by RT-qPCR. Freshly isolated Ik^L/L cells exhibited three- to sixfold increases in 3, 2b, and 2a GLT expression at the population level (Fig. 4 A). Further, SC-RT-PCR revealed that 22 and 6% of Ik^L/L cells expressed 3 and 2b GLTs, respectively, whereas virtually no WT cells expressed either GLT, suggesting that Ikaros represses the transcription of a subset of S regions in the absence of ex vivo stimulation (Fig. S7 and Table S1). After 48 h with LPS, LPS + IFN-, or LPS + IL-4, WT B cells specifically induced GLTs for the isotypes to which they switched (Fig. 1, A–C; and Fig. 4, B–D). Ik^L/L cells, however, expressed markedly different patterns of GLTs, and only derepressed GLTs correlated well with CSR. Strikingly, 2b and 2a GLTs were either overexpressed (>3.5-fold) or expressed ectopically (2b with LPS + IL-4, and 2a with LPS and LPS + IL-4) in Ik^L/L cells, and this expression correlated with increased or ectopic CSR to these isotypes (Fig. 1, A–C; Fig. 4, B–D; and Fig. S8). Similarly, 3 GLTs were expressed ectopically with LPS + IL-4 stimulation, which correlated with ectopic IgG₃ switching (Fig. 1 C and Fig. 4 D). In contrast, µ GLTs were expressed similarly in both genotypes, and surprisingly, despite expressing WT levels of 3 (with LPS and LPS + IFN-), 1 and GLTs, Ik^L/L cells switched less efficiently to these isotypes (Fig. 1, A–C; Fig. 2; and Fig. 4, B–D). Collectively, these results suggest that Ikaros represses the transcription of S3, S2b, and S2a in resting and stimulated cells, and that increased germline transcription of S2b and S2a (and S3 after LPS + IL-4) in Ikaros-deficient cells skews isotype selection during CSR.

View larger version (21K): [in this window] [in a new window] [Download PPT slide]   Figure 4. Deregulated expression of 3, 2b, and 2a GLTs in IkL/L B cells. GLTs expressed by B220+ WT and IkL/L B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were analyzed by qPCR. GLTs were normalized to Igβ levels and all values are represented relative to those of unstimulated WT B cells. Graphs represent means plus SD of three independent experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05).

View larger version (16K): [in this window] [in a new window] [Download PPT slide]   Figure 5. AcH4 correlates with transcriptional deregulation in IkL/L B cells. WT and IkL/L CD43– B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were subjected to ChIP with anti-AcH4 antibodies. Graphs represent the mean S region AcH4 enrichment indexes plus SD for three to four independent experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05). AcH4 at S2a was consistently higher in IkL/L versus WT samples after LPS + IFN- (S2a IkL/L/WT ratio mean = 1.68; range = 1.21–2.13).

Ikaros does not repress germline transcription by regulating promoter–enhancer interactions in the Igh locus
Germline transcription of S3, S2b, and S2a requires the Igh 3' enhancer (14, 15), and Ikaros has been reported to regulate long-range promoter–enhancer looping at the β-globin locus (35). Therefore, we asked if Ikaros regulates germline transcription by controlling interactions between the 3' enhancer and C_H gene promoters. Igh locus promoter–enhancer interactions were assayed in WT and Ik^L/L B cells by chromosome conformation capture (3C) to measure interactions between distal chromosome regions (36). In these experiments, interacting chromatin was cross-linked with formaldehyde, digested with a restriction enzyme, and subjected to intramolecular DNA ligation and qPCR amplification of ligation products (Fig. S9 shows digestion and PCR controls). We examined interactions between a HindIII fragment containing the HS1,2 regulatory site and fragments covering the µ enhancer, downstream C_H gene promoters, HS3a, and HS3b/4, as well as I regions not expected to participate in the regulation of germline transcription. Although HS1,2 was chosen as a reference point, patterns of promoter–enhancer cross-linking were similar, though weaker, using a 3' enhancer fragment containing HS3b/4 (unpublished data). WT and Ik^L/L B cells were compared, either before or after 36 h of stimulation, when germline transcription was efficiently induced, but CSR was barely detectable by FACS (unpublished data). B cell–specific interactions were identified by comparison with PMA-stimulated T cells in which the Igh locus is silent.

In freshly isolated B cells, but not T cells, HS1,2 was frequently cross-linked to a fragment containing the µ enhancer, as previously reported (Fig. 6 A) (16). This interaction was reduced but still present in Ik^L/L B cells, suggesting that Ikaros contributes to µ–3' enhancer interactions (Fig. 6 A). Cross-linking between HS1,2 and 3 or 2a in Ik^L/L B cells was similar to WT, despite ectopic 3, 2b, and 2a transcription; only HS1,2–2b interactions were increased in mutant cells (Fig. 4 A and Fig. 6 A). Thus no clear correlation was detected between C_H promoter–HS1,2 interactions and increased GLT expression in unstimulated Ik^L/L cells.

View larger version (19K): [in this window] [in a new window] [Download PPT slide]   Figure 6. Ikaros does not regulate interactions between HS1,2 and CH gene promoters. CD43– WT and IkL/L B cells were analyzed by 3C, either (A) before or after 36 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4. CD4+ T cells stimulated for 36 h with PMA served as a negative control. The y axis represents the relative cross-linking frequency between a HindIII fragment covering HS1,2 and the rest of the locus. Points represent means plus SD of two independent experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05). In A, HS1,2–HS3a and –HS3b/4 cross-linking frequencies in B cells, though similar between genotypes, were too high to be shown.

Ikaros maintains repressive chromatin at the 2b and 2a genes
AcH3 is a hallmark of transcriptionally active chromatin (37) and correlates tightly with germline transcription (17, 18). Thus, we asked if Ikaros could regulate S region transcription by controlling H3 acetylation. AcH3 was examined at C I exons and S regions in WT and Ik^L/L B cells by ChIP-qPCR, both before and after 48 h of stimulation. There were no significant differences in AcH3 levels between freshly isolated WT and Ik^L/L cells (Fig. 7 A). This suggests that AcH3 levels either do not contribute to GLT overexpression, or that our assay lacked the sensitivity required to detect differences in AcH3 associated with low levels of transcription (Fig. 4 A).

View larger version (18K): [in this window] [in a new window] [Download PPT slide]   Figure 7. Increased AcH3 at 3, 2b, and 2a in IkL/L B cells. WT and IkL/L CD43– B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were subjected to ChIP with anti-AcH3 antibodies. Graphs represent the mean I exon (I) and S region (S) AcH3 enrichment indexes plus SD for three independent experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05). S2b and S2a AcH3 levels were consistently higher in IkL/L versus WT samples after LPS + IFN- (S2b IkL/L/WT ratio mean = 2.68 [range = 1.82–3.47]; S2a IkL/L/WT ratio mean = 2.41 [range = 1.45–3.87]).

Ikaros interacts directly with the Igh locus
We next asked if Ikaros could control chromatin remodeling and S region transcription through direct binding to Igh regulatory regions. We analyzed Ikaros binding to the Igh locus in freshly isolated and stimulated WT B cells by ChIP-qPCR using anti-Ikaros antibodies. We focused on regions in the Igh 3' enhancer and C gene promoters, I exons and S regions, that contained Ikaros consensus sites identified with the TFSEARCH algorithm (38).

Ikaros associated with the Igh locus in vivo in WT B cells (Fig. 8). In freshly isolated CD43^– cells, Ikaros associated with I2b and HS1,2 in the 3' enhancer (Fig. 8 A). These associations were maintained after LPS stimulation (Fig. 8 B). When cells were stimulated with LPS + IFN-, Ikaros associated at low levels with I3 and at higher levels with I2b, I2a, and HS1,2 (Fig. 8 C). Interestingly, this stimulation also induced transcription at I3, I2b, and I2a, indicating that Ikaros associates strongly with some I exons upon their transcriptional activation (Fig. 8 C). Similarly, after LPS + IL-4 stimulation, Ikaros associated with the transcribed I1 exon (Fig. 4 D and Fig. 8 D). In addition, there was moderate Ikaros association with I2b, whereas the HS1,2 peak remained high (Fig. 8 D). Thus, Ikaros strongly associates with HS1,2 regardless of stimulation, with I2b in all conditions but most strongly when I2b is normally transcribed in WT, and with I3, I1, and I2a when they are transcriptionally induced upon stimulation.

View larger version (43K): [in this window] [in a new window] [Download PPT slide]   Figure 8. Ikaros associates with CH promoters and HS1,2 of the 3' enhancer. WT CD43– B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were subjected to ChIP-qPCR with anti-Ikaros antibodies. Points represent mean Ikaros enrichment, measured as percentage input, plus SD from two to three independent experiments. Approximate amplicon positions relative to transcription start sites or the 5' ends of HS sites are indicated. Dashed lines represent the mean percentage input for each condition and are defined as the threshold of specific Ikaros binding. (E and F) EMSAs were performed on putative Ikaros binding sites from sequences identified by ChIP (A–D). (E) Nuclear extracts from Cos cells transduced with an empty vector (V) or one encoding the Ik1 isoform (Ik) were incubated with the indicated probes (Table S2). Two putative I1 Ikaros binding sites were tested. (F) The HS1,2 probe was incubated with nuclear extracts from WT or IkL/L B cells stimulated for 36 h with LPS (L), LPS + IL-4 (4), or LPS + IFN- (I). Specificity was verified by supershift with anti-Ikaros antibodies. Arrowheads indicate Ikaros complexes. Data in E and F are representative of two independent experiments.

Ikaros controls transcriptional competition between S regions
The data described in the previous sections demonstrate that increased and ectopic transcription of 2b and 2a (and 3 with LPS + IL-4) in Ik^L/L cells correlates with enhanced/ectopic switching to these isotypes. Paradoxically, CSR to IgG₃, IgG₁, and IgE is decreased in Ik^L/L cells despite normal GLT levels (Figs. 1, 2, and 4). We hypothesized that this discrepancy was caused by increased/ectopic transcription of S2b/S2a (and S3) outcompeting transcription of other S regions for AID-mediated CSR. This model would require that (a) S regions are cotranscribed in individual cells and (b) transcription of S2b/S2a (and S3 with LPS + IL-4) is selectively increased relative to that of other S regions. To test this hypothesis, we examined the expression of aicda, and 3 and 2b GLTs (and actb as a positive control) by SC-RT-PCR in LPS- and LPS + IL-4–stimulated (48 h) IgM⁺ cells (Fig. 9 and Table S1). Importantly, because interallelic CSR occurs efficiently in WT cells (40, 41), SC-RT-PCR was performed without regard for allele. In LPS-stimulated WT cells, 97.1% of switching competent cells (e.g., aicda⁺) expressed GLTs for 2b (90.1%) and/or 3 (78.5%), which correlated with switching to these two isotypes (Fig. 1 A; and Fig. 9, B and C). Interestingly, 91.7% of 3 GLT⁺ cells also transcribed 2b, whereas 15–20% of WT cells switched to IgG₃ after 4 d, indicating that the majority of WT cells cotranscribe S regions and that cells cotranscribing 2b and 3 can still choose 3 for CSR (Fig. 3 and Fig. 9 C). In LPS + IL-4–stimulated cells, the high efficiency of IgG₁ switching suggests that 1 GLTs are expressed in almost all cells (Fig. 1 C); 1 PCRs were not performed because of the added complexity of performing a fifth PCR in multiplex. Interestingly, 53.9% of aicda⁺ WT cells expressed GLTs for 3 (34.3%) and/or 2b (29.8%), suggesting competition with S1 in a subset of WT cells (Fig. 9, B and C). However, by combining SC-RT-PCR and RT-qPCR data (Fig. 4, B and D), we calculated that the levels of S3 and S2b transcripts per 2b⁺/3⁺ cell were four times lower in LPS + IL-4–stimulated WT cells than in cells stimulated with LPS (Fig. 9 D). These low levels appear insufficient to induce CSR to 2b and 2a (Fig. 1 C). Thus, S regions are cotranscribed in WT cells and relative S region transcription rates per cell correlate with CSR, indicating that S region competition can occur under normal conditions and may regulate isotype choice.

View larger version (52K): [in this window] [in a new window] [Download PPT slide]   Figure 9. Increased S region competition at the SC level for CSR in IkL/L B cells. SC-RT-PCR was performed on IgM+ WT and IkL/L cells after 48 h of stimulation and two divisions (assessed by CFSE dilution). (A and B) Representative data from cohorts of (A) LPS- and (B) LPS + IL-4–stimulated cells are shown. Only actb+ wells were counted (positive control for sorting). Bar graphs represent mean percentages plus SD of cells positive for Aicda, or 3 or 2b GLTs, from two independent experiments (0, no cells; 1, one cell; raw data are shown in Table S1). (C) Pie charts represent mean percentages of aicda+ cells expressing GLTs for 3, 2b, both, or neither. The numbers of aicda+ cells analyzed over two experiments are indicated (chart centers). (D) Data from C was integrated with GLT expression levels measured by RT-qPCR (Fig. 4, B and D) to give a comprehensive view of 2b and 3 GLT expression in individual cells. Pie chart wedges represent the percentages of aicda+ B cells that express the indicated GLTs. Wedge radii are defined such that the wedge area corresponds to total GLT expression levels; 3 and 2b GLT levels were normalized to LPS-stimulated WT B cells, for which the radius was set to 1. Thus, the percentage of degrees out of 360 taken by each wedge corresponds to the percentage of expressing cells, and the wedge area corresponds to the integrated per cell expression level.

Similarly increased competition was found after LPS + IL-4 stimulation. 91.0% of aicda⁺ Ik^L/L cells expressed 3 (57.2%, up 22.9%) and/or 2b (83.8%, up 50.8%) GLTs, indicating that these S regions directly compete with S1 for CSR in most cells (Fig. 9, B and C). In addition, LPS + IL-4–stimulated Ik^L/L cells expressed 3 and 2b GLTs at per cell levels that were three- to fourfold higher than those found in similarly stimulated WT cells, and nearly equivalent to those observed in LPS-stimulated WT cells (Fig. 9 D). This correlated with ectopic CSR to these isotypes and reduced CSR to IgG₁ (Fig. 1 C). Thus, in LPS + IL-4–stimulated Ik^L/L cells, high levels of S2b/S3 transcription successfully compete with transcription of S1 for CSR.

Collectively, these observations demonstrate that the majority of B cells cotranscribe S regions, and that per cell transcription rates correlate with isotype selection. Further, our results strongly support the hypothesis that increased transcription of S2b and S2a (and S3 with LPS + IL-4) in Ik^L/L cells outcompetes transcription of other S regions for CSR and thus skews isotype selection.

	DISCUSSION

Top ABSTRACT RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES

 
In this study, we identify Ikaros as a critical regulator of Ig isotype selection in B cells during CSR. Ikaros deficiency results in increased and ectopic switching to IgG_2b and IgG_2a (and ectopic switching to IgG₃ with LPS + IL-4) and enhanced overall switching, but reduced switching to IgG₃ (with LPS and LPS + IFN-), IgG₁, IgE, and IgA. This function is independent of Ikaros’s role in B cell development, as inhibition of Ikaros in mature WT cells skews isotype selection to IgG_2b and IgG_2a, whereas retroviral expression of Ikaros in Ik^L/L B cells rescues CSR. Further, in direct correlation with their CSR phenotype, Ik^L/L cells exhibit sharp increases in transcription and AcH4, an AID-dependent histone mark, at S2b and S2a (and S3 with LPS + IL-4) but not other S regions. Ikaros directly binds the Igh locus in vivo and is required to prevent hyperacetylation of histone H3 at the 2b and 2a (and 3 with LPS + IL-4) genes upon B cell activation. Thus, Ikaros maintains repressive chromatin at 2b and 2a (and 3 with LPS + IL-4), and suppresses transcription, AID accessibility, and switching to these isotypes. These results identify Ikaros as the first factor that controls the range of isotypes targeted by CSR.

Our results also reveal that the choice to undergo CSR to specific C_H genes is controlled by the balance of germline transcription across different S regions within individual cells. We have shown that the majority of aicda⁺ LPS-stimulated WT cells coexpress GLTs for 2b and 3, suggesting competition between these two isotypes for switching. Further, selective increases in 2b GLTs in Ik^L/L cells, where 3 is always cotranscribed with 2b, correlate with increased CSR to IgG_2b and decreased CSR to IgG₃. Thus, repression of S2b transcription by Ikaros is required to maintain a balance between S2b and S3 transcription, allowing for normal switching to both isotypes. Similarly, Ikaros fine tunes S2b and S2a transcription in response to LPS + IFN-, to allow switching to IgG₃. Therefore, in addition to suppressing promiscuous switching to IgG_3/2b/2a in response to LPS + IL-4, and IgG_2a in response to LPS, Ikaros limits transcription across S2b and S2a so that germline transcription of other S regions (i.e., S3 and S) can effectively compete for switching. These results indicate that the isotype fate of individual cells during CSR is determined by the relative levels of germline transcription across different S regions. Considering that single human B cells have also been reported to transcribe multiple S regions simultaneously (42), this is likely a general mechanism, across species, for isotype selection during CSR.

A question arising from our work is how Ikaros suppresses transcription at 3, 2b, and 2a. Interestingly, we have found that histone H3 is hyperacetylated at these genes in Ik^L/L cells. Although it is possible that these increased AcH3 levels result from transcription-coupled processes, it is attractive to speculate that Ikaros regulates germline transcription by maintaining a repressive chromatin structure. In this respect, it is well documented that histone acetylation contributes to transcription by opening chromatin and/or providing binding platforms for regulatory factors (43, 44).

Considering that H3 is hyperacetylated in Ik^L/L cells and that Ikaros interacts with the Sin3 and NuRD histone deacetylase (HDAC) complexes (45–48), we expected Ikaros to recruit these complexes to the Igh locus to regulate germline transcription. However, we have been unable to find reduced Igh locus occupancy for Sin3a, Mi-2β (a core member of NuRD), HDAC1, or HDAC2 in Ik^L/L versus WT cells by ChIP-qPCR or double cross-linking (DC)–ChIP-qPCR (Fig. S10). Furthermore, shRNA knockdown of Mi-2β in WT B cells neither increased 2b transcription nor altered switching specificity (Fig. S11). These data indicate that Ikaros does not suppress H3 acetylation and germline transcription by recruiting the NuRD and Sin3 HDAC complexes to the Igh locus.

Our results indicate that Ikaros may directly regulate germline transcription through the HS1,2 region of the Igh 3' enhancer. Ikaros associates with HS1,2 in all conditions tested, and Ikaros proteins bind directly to a sequence in this region in vitro. In contrast, despite the association of Ikaros with the I1, I2b, and I2a regions by ChIP, we were unable to identify sequences in these regions that could be strongly and directly bound by Ikaros. Although we cannot rule out binding to noncanonical sites, these data suggest that Ikaros binds directly to HS1,2 and interacts indirectly with I1, I2b, and I2a. Our 3C data, as well as those from Wuerffel et al. (16), support this interpretation, as HS1,2 interacts with fragments containing the 3, 1, 2b, and 2a I promoters/exons. Interestingly, HS1,2–1 interactions increase when this gene is transcribed (e.g., LPS + IL-4; Figs. 4 and 6) (16), which correlates with the appearance of an Ikaros binding peak by ChIP. Similarly, Ikaros associates with I2a only when cells are stimulated with LPS + IFN-, which induces both 2a GLTs and increased HS1,2-I2a interactions. Thus, we propose that Ikaros interacts indirectly with and regulates C_H gene promoters through HS1,2.

The idea that Ikaros mediates repression through the HS1,2 regulatory region of the 3' enhancer is bolstered by the observation that 3' enhancer disruption most drastically affects transcription of and CSR to 3, 2b, and 2a, the C_H genes most strongly affected by Ikaros deficiency (14, 15). One issue with this model is that HS1,2 deletion does not affect CSR (14), suggesting that HS1,2 may be not be functionally important for CSR and/or that it functions independently of Ikaros. This explanation, however, is probably too simplistic. In another complex locus, the β-globin locus, deletions of individual regulatory elements result in little to no phenotype, whereas combined deletions can drastically inhibit globin gene expression, indicating that the loss of individual elements can be compensated for by redundant functions in other regions (49). Thus, compensation by other 3' enhancer elements, which have many similar transcription factor motifs (50), could explain the lack of CSR phenotype in HS1,2^–/– cells. In addition, HS1,2 can strongly synergize with other HS fragments to activate transcription (51), and the core region HS1,2 is highly conserved between mouse, rat, rabbit, and human (52), indicating that HS1,2 is likely to play important roles in CSR.

How then, can HS1,2^–/– and Ik^L/L B cell CSR phenotypes be reconciled? An obvious possibility is that Ikaros could repress germline transcription and histone acetylation by antagonizing positive regulatory functions at this element. In this case, HS1,2 deletion would abolish both negative regulation by Ikaros and positive regulation by unknown factors, resulting in a neutral phenotype. In contrast, Ikaros deficiency would allow increased activity by positively acting factors, resulting in a significant phenotype. Interestingly, Ikaros has been shown to compete with positive regulators to modulate the transcription of target genes in other settings (22, 53, 54). In this respect, our EMSA assay indicates that multiple factors can bind at or near the HS1,2–Ikaros binding site (Fig. 8 F). Thus, it will be important to determine if Ikaros competes with other factors for binding to the HS1,2 regulatory element to fine tune germline transcription.

Finally, the efficiency of CSR is controlled by several mechanisms, including cell proliferation, AID expression, subcellular localization and posttranslational modifications, DSB formation, DNA repair, S region synapsis, and end joining (1). Our results suggest that S region transcription rates in WT cells also limit switching efficiency. This concept is supported by (a) the low rates of CSR compared with switching competency in WT cells (30% of cells switched after 4 d with LPS, whereas 70% were aicda⁺GLT⁺ after 48 h; Fig. 3, Fig. 9A, and Table S1), (b) the similar levels of CSR-competent cells in Ik^L/L and WT cultures (67% of Ik^L/L cells were aicda⁺GLT⁺ after 48 h; Fig. 9 A and Table S1), and (c) the direct correlation between increased per cell GLT levels, AID accessibility, and switching frequency in Ik^L/L cells (50% switched after 4 d; Fig. 5 B, Fig. 9 D, and Fig. S5 B). Why it would be advantageous to limit S region transcription rates and CSR efficiency under normal conditions is not clear. This mechanism could result in more flexible humoral immune responses in vivo, as slowing the rate of CSR may prevent B cells from switching en masse soon after activation, thus allowing isotype selection to be modified over time. In addition, reduced S region transcription, and therefore DSB formation, would decrease the probability of unrepaired DSBs, which can to lead to oncogenic translocations (55).

In summary, our results reveal transcriptional competition between constant region genes as a central and general mechanism for isotype specification during CSR. We have shown that Ikaros is a master regulator of this competition.

	MATERIALS AND METHODS

Top ABSTRACT RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES

 
Mice.
The Ik^L/L mouse line was previously described (21). Mice backcrossed >10 times onto the C57BL/6 genetic background were analyzed at 5–9 wk of age. All animal work was performed under protocols approved by the Direction des Services Vétérinaires du Bas-Rhin, France (authorization no. 67-343).

Cell culture.
Spleen cells were used for all experiments. B cells (B220⁺, IgM⁺CD43^–, or CD43^–IgG/A^– cells; >98% purity) were sorted on a FACSVantage SE option DIVA (BD) or enriched by depletion of CD43⁺ cells with MACS beads (>90% purity), and CD4⁺ T cells were isolated with anti-CD4 MACS beads (>90% purity; Miltenyi Biotech). Cells were labeled with 5 µg/ml CFSE (10 min at 37°C; Sigma-Aldrich) and were maintained at 1.2 x 10⁶ cells/ml in complete medium (RPMI 1640, 10% FCS, 25 mM Hepes, 1 mM sodium pyruvate, 2 mM L-glutamine, 1x nonessential amino acids, 5 x 10^–5 M 2-mercaptoethanol, and 1% antibiotics) with 25 µg/ml LPS (serotype 0111:B4 from Escherichia coli; Sigma-Aldrich), 5 ng/ml IL-4 (Sigma-Aldrich), 100 ng/ml IFN- (PeproTech), 3 ng/ml TGF-β (R&D Systems), 5 ng/ml IL-5 (BD), and 0.5 ng/ml PMA (Sigma-Aldrich).

Flow cytometry.
Reagents included anti-B220–FITC (RA3-6B2), anti–mouse IgG_2b–biotin (RMG2b-1; BioLegend), anti–mouse IgA–PE (SouthernBiotech), F(ab')₂ goat anti–mouse IgM–Cy5 and streptavidin-Cy5 or -PE (Jackson ImmunoResearch Laboratories), anti–mouse IgG₃–biotin (R40-82), anti–mouse IgG₁–biotin (A85-1), anti–mouse IgG_2a^b–biotin (Igh-b; 5.7) and anti-CD43–PE (BD), goat anti–mouse IgG (H+L)–biotin (Invitrogen), anti-NGFR–Cy5 (8737; provided by W. Pear, University of Pennsylvania, Philadelphia, PA), and 7-aminoactinomycin D (Sigma-Aldrich). Cells were analyzed with a FACSCalibur (BD) and FlowJo software (Tree Star, Inc.).

RT-qPCR.
RNA was isolated with RNeasy kits (QIAGEN). 350 ng RNA was reverse transcribed in 20 µl (50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgCl₂, 10 mM dithiothreitol, 500 µM dNTP, 10 U recombinant RNasin ribonuclease inhibitor [Promega], 0.5 µM oligo d(T) [New England Biolabs, Inc.], and 40 U SuperScript II RT [Invitrogen]). SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) was used for all qPCRs. Approximately 3 ng of cDNA was run (in triplicate) on a LightCycler 480 (96-well plate format) and analyzed with LightCycler 480 basic software (Roche). Transcript quantities for each gene were calculated relative to standard curves and normalized to Igβ transcripts. Gene of interest/Igβ ratios for each condition were averaged across experiments and normalized to the indicated WT condition, to give relative expression versus WT or versus unstimulated WT, as noted. Table S2 lists oligonucleotides for all experiments.

SC-RT-PCR.
Two rounds of PCR were performed with fully nested primers, as previously described (54). Only actb⁺ wells were analyzed (>90%).

Retrovirus production and transduction.
MigR1-NGFR (provided by W. Pear) is an murine stem cell virus–based retrovirus (56). Ik1 cDNA was amplified from mouse spleen cDNA by PCR (bp 271–1,818; available from GenBank/EMBL/DDBJ under accession no. NM_001025597). Ik1* cDNA was obtained by site-directed mutagenesis to delete exon 2–derived Ik1 sequences (bp 310–430). Ik6 cDNA was obtained by fusing PCR fragments for exons 1 and 2 (bp 271–429) and exon 7 (bp 1,117–1,818) of Ik1. cDNAs were cloned into the MigR1-NGFR vector and were designated Ik1-NGFR, Ik1*-NGFR, and Ik6-NGFR. pQsupR-Mi2 (Mi-2β shRNA; provided by S. Smale, University of California, Los Angeles, Los Angeles, CA) and pQsupR (mock) vectors were previously described (57). Vectors were transfected into Eco-Phoenix packaging cells (provided by G. Nolan, Stanford University, Stanford, CA) to produce high-titer retroviral supernatants. 3.5 x 10⁵ CFSE-stained cells (1.2 x 10⁶ cells/ml) were cultured in LPS for 24 h, transduced with retroviral supernatant (25% total vol; 4 µg/ml polybrene; 25 µg/ml LPS), and centrifuged for 90 min at 2,600 rpm. Medium was replaced after 12 h and cells were analyzed 60 h later.

ChIP.
The ChIP protocol was adapted from Wang et al. (18) and Millipore (http://www.millipore.com/techpublications/tech1/mcproto407). In brief, 1.8 x 10⁷ B cells were cross-linked at 37°C for 10 min in 5 ml PBS/0.5% BSA/1% ultra-pure formaldehyde (Electron Microscopy Sciences). After quenching with 0.125 M glycine and a cold PBS wash (with 1x protease inhibitor cocktail [PIC]; Roche), cells were lysed in 5 ml of Triton X lysis buffer for 10 min on ice (1% Triton X-100, 50 mM MgCl₂, 100 mM Tris-HCl [pH 7.1], 11% sucrose, 1x PIC). Nuclei were pelleted at 2,000 rpm for 10 min (4°C) and were lysed in 500 µl of SDS lysis buffer for 10 min on ice (1% SDS, 50 mM Tris-HCl, 10 mM EDTA, 1x PIC). Chromatin was sonicated to 500-1,000 bp using a Bioruptor 200 (Diagenode), and sonication efficiency was checked. After 2x dilution in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1], 167 mM NaCl), chromatin was precleared by rotating for 2 h at 4°C with 80 µl 50% protein A slurry (0.2 mg/ml sheared salmon sperm DNA, 0.5 mg/ml BSA, 50% protein A; GE Healthcare). 1.3 x 10⁶ cell equivalents were saved as input. 3.9 x 10⁶ cell equivalents were incubated overnight with 2 µg anti-AcH3 (Millipore), 2 µg anti-AcH4 (Millipore), 2.5 µg anti-Ikaros (rabbit anti–mouse produced in house), anti–Mi-2β (5 µl of rabbit serum; gifts from P. Wade [National Institute of Environmental Health Sciences, Research Triangle Park, NC] and S. Smale), 5 µg anti-Sin3a (Santa Cruz Biotechnology, Inc.), 5 µg anti-HDAC1 (Abcam), 5 µg anti-HDAC2 (Abcam), and control antibodies (Bethyl Laboratories). ChIPs were recovered with 65 µl 50% protein A slurry for 5 h and processed according to the Millipore protocol. ChIP and input DNA was dissolved in 140 µl TE buffer (10 mM Tris-HCl, 1 mM EDTA [ph 8]), and inputs were diluted 10 times. 2-µl aliquots were analyzed (in duplicate) by qPCR. Calculations were as follows: percentage input (%I) = 100 x ([antibody bound] – [IgG bound])/(input*10); and histone acetylation index = (%I^{Igh sequence})/(%I^{Hprt promoter}). For DC-ChIP, cells were first fixed with disuccinimidyl glutarate (58).

3C.
3C was performed as previously described (59) with some modifications. In brief, 11 x 10⁶ cells were fixed for 10 min in 10 ml 1x PBS/0.5% BSA/1.5% formaldehyde (Electron Microscopy Sciences) at room temperature with tumbling (10 rpm). Fixation was quenched with 0.125 M glycine. Cells were washed one time in cold PBS/1x PIC and lysed for 10 min on ice in 1 ml of lysis buffer (10 mM Tris [pH 8], 10 mM NaCl, 0.2% NP-40, 1x PIC). After centrifugation, cells were resuspended in 537 µl of digestion buffer (60 µl of 10x buffer R [Fermentas], 1x PIC). SDS was added to 0.3% and samples were rotated for 1 h at 37°C (99 rpm). Triton X was added to 1.8% to sequester SDS, bringing the total volume to 600 µl. Samples were rotated (99 rpm) for 1 h at 37°C before overnight digestion with 500 U HindIII (50 rpm; New England Biolabs, Inc.). HindIII was inactivated by adding SDS to 1.75% and incubating for 20 min at 65°C. 10⁶ cell equivalents were removed, de–cross-linked, and analyzed by qPCR to monitor digestion efficiency (routinely 80–90%; Fig. S9 A). 10⁷ cell equivalents were diluted to 8 ml in 1x ligation buffer (New England Biolabs), 1% Triton X, and 1x PIC, and SDS was sequestered by rocking for 1 h at 37°C. 4,000 NEB U of ligase (New England Biolabs, Inc.) were added and samples were rocked for 10 min at 4°C before incubation for 6 h at 16°C, followed by 30 min at room temperature. Samples were de–cross-linked overnight at 65°C with 300 µg protease K and were retreated with 300 µg protease K for 1 h at 45°C. DNA was extracted using ultra-pure phenol/chloroform/isoamyl alcohol (25:24:1; Invitrogen), washed two times with chloroform, ethanol precipitated with 2.5 M ammonium acetate, and washed four times with 75% ethanol. After suspension in TE, relative DNA concentrations were calculated by qPCR (ChIP primers "HS4 –0.5 kb").

Ligation products were analyzed by qPCR in duplicate or triplicate using 200 ng DNA. Absolute quantities were calculated using a template consisting of equimolar ratios of all possible ligation products. The template was constructed as previously described (60) with PCR fragments from the Igh and Gapd loci and diluted in genomic DNA. qPCR specificity was confirmed with negative controls (without fixation, digestion, or ligation), melting point analysis, digestion of PCR products with HindIII, and migration of PCR and digestion products on 2% agarose gels (Fig. S9 B). Relative cross-linking frequency was calculated as follows: cross-linking frequency = ([HS1,2 – fragment X]/[HS4 –0.5 kb loading control])/([Gapd 3' – Gapd 5']/[HS4 –0.5 kb]).

EMSA.
Nuclear extracts (NEs) and EMSAs were prepared as previously described (61). 2.5 µg NE from Cos cells transfected with mock cDNA or cDNA coding for Ik1 proteins or 4 µg NE from CSR-induced B cells was used.

Online supplemental material.
Table S1 summarizes raw data from SC-RT-PCR experiments. Table S2 lists oligonucleotides. Fig. S1 shows statistical analysis of WT and Ik^L/L CSR frequencies after LPS, LPS + IL-4, LPS + IFN-, and LPS + IL-5 + TGF-β stimulation. Fig. S2 quantifies Ig isotype production by WT and Ik^L/L B cells using ELISA. Fig. S3 analyzes WT and Ik^L/L CSR frequency as a function of proliferation. Fig. S4 examines CSR in whole and bona fide unswitched WT and Ik^L/L B cells. Fig. S5 shows the effect of retroviral expression of dominant-negative Ikaros on CSR in WT cells, and full-length and exon 2–deleted Ikaros isoforms on CSR in Ik^L/L B cells. Fig. S6 shows RT-qPCR analysis of aicda expression in stimulated WT and Ik^L/L cells. Fig. S7 shows SC-RT-PCR analysis of aicda, 3 GLT, and 2b GLT expression in freshly isolated IgM⁺CD43^– B cells and CD4⁺CD3⁺ T cells. Fig. S8 shows RT-qPCR analysis of µ, 3, 2b, and 2a GLT expression in WT and Ik^L/L B cells after 48 h with LPS and one or three divisions. Fig. S9 shows digestion efficiency and PCR specificity controls for 3C experiments. Fig. S10 shows ChIP-qPCR and DC-ChIP-qPCR for Mi-2β, Sin3a, HDAC1, and HDAC2 at the Igh locus in WT and Ik^L/L cells. Fig. S11 shows the effect of Mi-2β shRNA knockdown on CSR in WT B cells. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20082311/DC1.